462 related articles for article (PubMed ID: 19886313)
21. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.
Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG
Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881
[TBL] [Abstract][Full Text] [Related]
22. Exit-site/tunnel infection and catheter outcome in peritoneal dialysis patients.
Wadhwa NK; Cabralda T; Suh H; Kvilekval K; Mason R
Adv Perit Dial; 1992; 8():325-7. PubMed ID: 1361816
[TBL] [Abstract][Full Text] [Related]
23. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis.
Pierce DA; Williamson JC; Mauck VS; Russell GB; Palavecino E; Burkart JM
Perit Dial Int; 2012; 32(5):525-30. PubMed ID: 22302770
[TBL] [Abstract][Full Text] [Related]
24. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
[TBL] [Abstract][Full Text] [Related]
25. Microbial spectrum and outcome of peritoneal dialysis related peritonitis in Qatar.
Shigidi MM; Fituri OM; Chandy SK; Asim M; Al Malki HA; Rashed AH
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):168-73. PubMed ID: 20061719
[TBL] [Abstract][Full Text] [Related]
26. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
[TBL] [Abstract][Full Text] [Related]
27. Frequency of various types of peritoneal catheter infections and therapeutic outcome of treatment.
Gucek A; Benedik M; Zakelj B; Stanisavljevic D; Lindic J; Hergouth V; Bren AF
Adv Perit Dial; 1995; 11():149-51. PubMed ID: 8534690
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients.
Sachar M; Shah A
Ther Apher Dial; 2022 Apr; 26(2):275-287. PubMed ID: 34435734
[TBL] [Abstract][Full Text] [Related]
29. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
[TBL] [Abstract][Full Text] [Related]
30. Lack of correlation between nasal cultures positive for Staphylococcus aureus and the development of S. aureus exit-site infections: results unaffected by routine mupirocin treatment of nasal S. aureus carriage.
Hanslik TM; Newman L; Tessman M; Morrissey AB; Friedlander MA
Adv Perit Dial; 1994; 10():158-62. PubMed ID: 7999817
[TBL] [Abstract][Full Text] [Related]
31. [Prophylaxis and management of catheter-associated infections in peritoneal dialysis patients: recent studies and guidelines].
Kopriva-Altfahrt G; Moser E; Prokschi A; Kraus B; Kovarik J
Wien Klin Wochenschr; 2005; 117 Suppl 6():73-82. PubMed ID: 16437337
[TBL] [Abstract][Full Text] [Related]
32. Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis.
Cavdar C; Atay T; Zeybel M; Celik A; Ozder A; Yildiz S; Gulay Z; Camsari T
Adv Perit Dial; 2004; 20():67-70. PubMed ID: 15384798
[TBL] [Abstract][Full Text] [Related]
33. A ten-year single-centre experience in children on chronic peritoneal dialysis--significance of percutaneous placement of peritoneal dialysis catheters.
Aksu N; Yavascan O; Anil M; Kara OD; Erdogan H; Bal A
Nephrol Dial Transplant; 2007 Jul; 22(7):2045-51. PubMed ID: 17438008
[TBL] [Abstract][Full Text] [Related]
34. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis.
Kingwatanakul P; Warady BA
Adv Perit Dial; 1997; 13():281-4. PubMed ID: 9360700
[TBL] [Abstract][Full Text] [Related]
35. Staphylococcus aureus infections during peritoneal dialysis.
Coles GA
J Chemother; 1995 Jul; 7 Suppl 3():67-70. PubMed ID: 8609540
[TBL] [Abstract][Full Text] [Related]
36. Outcome of Pseudomonas aeruginosa exit-site and tunnel infections: a single center's experience.
Szabo T; Siccion Z; Izatt S; Vas SI; Bargman J; Oreopoulos DG
Adv Perit Dial; 1999; 15():209-12. PubMed ID: 10682104
[TBL] [Abstract][Full Text] [Related]
37. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.
McQuillan RF; Chiu E; Nessim S; Lok CE; Roscoe JM; Tam P; Jassal SV
Clin J Am Soc Nephrol; 2012 Feb; 7(2):297-303. PubMed ID: 22134627
[TBL] [Abstract][Full Text] [Related]
38. The risk of peritonitis after an exit site infection: a time-matched, case-control study.
Lloyd A; Tangri N; Shafer LA; Rigatto C; Perl J; Komenda P; Sood MM
Nephrol Dial Transplant; 2013 Jul; 28(7):1915-21. PubMed ID: 23382265
[TBL] [Abstract][Full Text] [Related]
39. Treatment of mycobacterial exit-site infections in patients on continuous ambulatory peritoneal dialysis.
Kleinpeter MA; Krane NK
Adv Perit Dial; 2001; 17():172-5. PubMed ID: 11510269
[TBL] [Abstract][Full Text] [Related]
40. Outcome of peritoneal dialysis: Tenckhoff catheter survival in a prospective study.
Ortiz AM; Fernandez MA; Troncoso PA; Guzmán S; Del Campo F; Morales RA
Adv Perit Dial; 2004; 20():145-9. PubMed ID: 15384816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
